Have a personal or library account? Click to login
The Effect of Inhalation Volume and Breath-Hold Duration on the Retention of Nicotine and Solanesol in the Human Respiratory Tract and on Subsequent Plasma Nicotine Concentrations During Cigarette Smoking Cover

The Effect of Inhalation Volume and Breath-Hold Duration on the Retention of Nicotine and Solanesol in the Human Respiratory Tract and on Subsequent Plasma Nicotine Concentrations During Cigarette Smoking

Open Access
|Dec 2014

References

  1. 1. Houseman, T.H.: Studies of cigarette smoke transfer using radio-isotopically labelled tobacco constituents. Part II: The transference of radio-isotopically labelled nicotine to cigarette smoke; Beitr. Tabakforsch. 7 (1973) 142–147.
  2. 2. Lewis, D.A., I. Colbeck, and D.C. Mariner: Dilution of mainstream tobacco smoke and its effects upon the evaporation and diffusion of nicotine; J. Aerosol. Sci. 26 (1995) 841–846.
  3. 3. Stevens, N.A. and M.F. Borgerding: GC-AED studies of nicotine fate in a burning cigarette; Anal. Chem. 72 (1999) 2179–2185.
  4. 4. Chen, B.T., J. Namenxi, H.C. Yen, J.L. Mauderly, and R.G. Cuddihy: Physical characterization of cigarette smoke aerosol generated from a Walton smoke ma-chine; Aerosol Sci. Technol. 12 (1990) 364–375.
  5. 5. Russell, M.A.H. and C. Feyerabend: Cigarette smoking: a dependence on high-nicotine boli; Drug. Metab. Rev. 8 (1978) 29–57.
  6. 6. Frost, B.E., D.C. Mariner, and N.M. Sinclair: Factors relating to nicotine physio-chemistry and retention in human smokers; in: Proceedings of the CORESTA Congress, October 1998, Brighton, UK, 211–218.
  7. 7. Rose, J.E., F.M. Behm, E.C. Westman, and R.E. Coleman: Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction; Drug Alcohol Dependence 56 (1999) 99–107.
  8. 8. Sterling, E.M., C.W. Collett, and J.A. Ross: Assess-ment of non-smokers exposure to environmental tobacco smoke using personal-exposure and fixed location monitoring; Indoor Built Environment 5 (1996) 112–125.
  9. 9. ISO 4387: Methods for chemical analysis of tobacco and tobacco products. Determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine; International Organisation for Standardisation, Geneva, 1991.
  10. 10. ISO 10315: Methods for chemical analysis of tobacco and tobacco products. Determination of nicotine in smoke condensate of cigarettes (gas-chromatographic method); International Organisation for Standardisation, Geneva, 1991.
  11. 11. ISO 8454: Methods for chemical analysis of tobacco and tobacco smoke products. Determination of carbon monoxide in the vapour phase of cigarette smoke (NDIR method); International Organisation for Stand-ardisation, Geneva, 1995.
  12. 12. Creighton, D.E., M.J. Noble, and R.T. Whewell: Instruments to measure, record and duplicate human smoking patterns; in: Smoking Behaviour, edited by R.E. Thornton, Churchill Livingstone, Edinburgh, London and New York, 1978, pp. 277–288.
  13. 13. US Department of Health and Human Services (USDHHS): The health consequences of smoking: Nicotine addiction; Public Health Services, Washington DC, 1988.
  14. 14. Guyatt, A.R., M.A. Holmes, and G. Cumming: Can carbon monoxide be absorbed from the upper respiratory tract in man? Eur. J. Respir. Dis. 62 (1981) 383–390.
  15. 15. Creighton, D.E. and P.H. Lewis: The effect of smoking pattern on smoke deliveries; in: Smoking Behaviour, edited by R.E. Thornton, Churchill Livingstone, Edinburgh, London and New York, 1978, pp. 289–314.
  16. 16. American Society for Testing and Materials: D6271-98, Standard test method for estimating contribution of environmental tobacco smoke to respirable suspended particles based on solanesol, 1998.
  17. 17. American Society for Testing and Materials: D5075-96e1, Standard test method for nicotine and 3-ethenyl-pyridine in indoor air, 1996.
  18. 18. Dixon, M., K. Lambing, and J.I. Seeman: On the transfer of nicotine from tobacco to the smoker. A brief review of ammonia and “pH” factors; Beitr. Tabak-forsch. Int. 19 (2000) 103–113.
  19. 19. Black, A., J.J. McAughey, D.A. Knight., C.J. Dickens, and J.C. Strong: Estimation of ETS retention in volunteers from measurements of exhaled smoke composition; in: Indoor Air ’93, edited by M. Jantunen, P. Kalliokoski, E. Kukkonen, K. Saarela, O. Seppanen, and H. Vuorelma, Indoor Air 1993, Vol. 3, Helsinki, Finland, pp. 41–46.
  20. 20. Zacny, J.P., M.L. Stitzer, F.J. Brown, J.E. Yingling, and R.R. Griffiths: Human cigarette smoking: Effects of puff and inhalation parameters on smoke exposure; J. Pharm. Exp. Ther. 240 (1987) 554–564.
  21. 21. Gori, G.B., N.L. Benowitz, and C.J. Lynch: Mouth versus deep airway absorption of nicotine in cigarette smokers; Pharmacol. Biochem. Behav. 25 (1986) 1181–1186.
  22. 22. Lunell, E., M. Bergstrom, G. Antoni, B. Langstrom, and A. Nordbert: Nicotine deposition and body distri-bution from a nicotine inhaler and a cigarette studied with positron emission tomography; Clin. Pharmacol. Ther. 59 (1996) 593–594.
  23. 23. Bergstrom, M., A. Nordberg, E. Lunell, G. Antoni, and B. Langstrom: Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography; Clin. Pharmacol. Ther. 57 (1995) 309–317.
  24. 24. Russell, M.A.H., M.J. Jarvis, G. Sutherland, and C. Feyerabend: Nicotine replacement in smoking cessation; J. Amer. Med. Assoc. 257 (1987) 3262–3265.
  25. 25. Schuh,K.J., L.M. Schuh, J.E. Henningfield, and M.L. Stitzer: Nicotine nasal spray and vapor inhaler: Abuse liability assessment; Pyschopharmacology 130 (1997) 352–361.
  26. 25. Molander, L., E. Lunell, S.-B. Anderson, and F. Kuylenstierna: Dose released and absolute bioavailabi-lity of nicotine from a nicotine vapour inhaler; Clin. Pharmacol. Ther. 59 (1996) 394–400.
  27. 27. Schievelbein, H: Nicotine, resorption and fate; in: International Encyclopedia of Pharmacology and Therapeutics, Section 114: Nicotine and the tobacco smoking habit, edited by D.J.K. Balfour, Pergamon Press, 1984, pp. 1–15
  28. 28. US Department of Health and Human Services (USDHHS): The health consequences of using smoke-less tobacco: Public Health Services, Washington DC, 1986.
  29. 29. Henningfield, J.E., A. Radzius, and E.J. Cone: Estimation of available nicotine content of six smokeless tobacco products; Tob. Control 4 (1995) 57–61.
  30. 30. Djordjevic, M., D. Hoffman, T. Glynn, and G. Con-nolly: US commercial brands of moist snuff, 1994. Assessment of nicotine, moisture and pH; Tob. Control 4 (1995) 62–66.
  31. 31. Martonen, T.B. and C.J. Musante: Importance of cloud motion on cigarette smoke deposition in the lung; Inhal. Toxicol. 12 (2000) 261–280.
  32. 32. Pankow, J.F: A consideration of the role of gas/particle partitioning in the deposition of nicotine and other tobacco smoke compounds in the respiratory tract; Chem. Res. Toxicol. 14 (2001) 1465–1481.
Language: English
Page range: 240 - 249
Submitted on: Jan 12, 2004
|
Accepted on: Aug 16, 2004
|
Published on: Dec 30, 2014
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 AK Armitage, M Dixon, BE Frost, DC Mariner, NM Sinclair, published by Institut für Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.